| Product Code: ETC9967090 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Gonorrhea Diagnostic Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Gonorrhea Diagnostic Market - Industry Life Cycle |
3.4 United States (US) Gonorrhea Diagnostic Market - Porter's Five Forces |
3.5 United States (US) Gonorrhea Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Gonorrhea Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Gonorrhea Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gonorrhea cases in the United States |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in diagnostic tools for gonorrhea |
4.3 Market Restraints |
4.3.1 Limited accessibility to diagnostic services in certain regions |
4.3.2 High cost associated with advanced diagnostic tests |
4.3.3 Regulatory challenges in the approval of new diagnostic technologies |
5 United States (US) Gonorrhea Diagnostic Market Trends |
6 United States (US) Gonorrhea Diagnostic Market, By Types |
6.1 United States (US) Gonorrhea Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Flow cytometry, 2021- 2031F |
6.1.4 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Diagnostic imaging, 2021- 2031F |
6.1.5 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Gel micro-droplets, 2021- 2031F |
6.1.6 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Artificial intelligence, 2021- 2031F |
6.1.7 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Chromatography, 2021- 2031F |
6.1.8 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Differential light scattering (DLS), 2021- 2031F |
6.2 United States (US) Gonorrhea Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Personal use, 2021- 2031F |
6.2.4 United States (US) Gonorrhea Diagnostic Market Revenues & Volume, By Research, 2021- 2031F |
7 United States (US) Gonorrhea Diagnostic Market Import-Export Trade Statistics |
7.1 United States (US) Gonorrhea Diagnostic Market Export to Major Countries |
7.2 United States (US) Gonorrhea Diagnostic Market Imports from Major Countries |
8 United States (US) Gonorrhea Diagnostic Market Key Performance Indicators |
8.1 Rate of gonorrhea testing per capita in the United States |
8.2 Adoption rate of new gonorrhea diagnostic technologies |
8.3 Number of healthcare facilities offering gonorrhea diagnostic services |
9 United States (US) Gonorrhea Diagnostic Market - Opportunity Assessment |
9.1 United States (US) Gonorrhea Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Gonorrhea Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Gonorrhea Diagnostic Market - Competitive Landscape |
10.1 United States (US) Gonorrhea Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Gonorrhea Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |